Journal article
Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics
Authors
Vinagre I; Gerstein H; Viñals C; Conget I
Journal
Endocrinología Diabetes y Nutrición (English ed ), Vol. 66, No. 7, pp. 467–468
Publisher
Elsevier
Publication Date
August 1, 2019
DOI
10.1016/j.endinu.2019.01.005
ISSN
2530-0180
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedCardiovascular DiseasesClinical Trials as TopicCombined Modality TherapyComorbidityDiabetes ComplicationsDiabetes Mellitus, Type 2DyslipidemiasFemaleGlucagon-Like PeptidesHumansHypoglycemic AgentsImmunoglobulin Fc FragmentsMaleMiddle AgedMulticenter Studies as TopicPrimary Health CareRecombinant Fusion ProteinsRisk FactorsSmokingSpain